Position in BMY
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$2,107,681
-$181,735 QoQ
Shares Held
36,579
-3.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#815
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LEAVELL INVESTMENT MANAGEMENT, INC. holds $56,783,148 across 9 Drug Manufacturers - General names. BMY ranks #6 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
74,935 | $18,856,643 | |
| 2 | LLY |
ELI LILLY & Co
|
9,341 | $11,203,876 | |
| 3 | JNJ |
Johnson & Johnson
|
40,591 | $10,308,896 | |
| 4 | AMGN |
Amgen Inc
|
17,935 | $6,494,622 | |
| 5 | MRK |
Merck & Co., Inc.
|
41,794 | $5,370,529 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
36,579 | $2,107,681 | |
| 7 | AZN |
Astrazeneca PLC
|
6,562 | $1,244,286 | |
| 8 | PFE |
Pfizer Inc
|
35,669 | $858,909 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,107,681 | 36,579 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $2,289,416 | 37,748 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,013,202 | 37,323 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,690,032 | 37,473 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $1,758,418 | 37,987 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,441,490 | 40,031 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $2,206,292 | 39,008 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $1,884,681 | 36,426 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $929,109 | 22,372 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $1,413,884 | 26,072 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $1,329,647 | 25,914 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $1,620,708 | 27,924 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $1,645,753 | 25,735 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $1,826,872 | 26,358 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $2,070,433 | 28,776 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $2,053,079 | 28,880 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $2,226,532 | 28,916 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $2,073,613 | 28,394 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $1,788,572 | 28,686 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $1,698,415 | 28,704 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $2,301,949 | 34,450 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $2,174,828 | 34,450 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $1,948,548 | 31,413 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $2,609,893 | 43,289 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $2,712,032 | 46,123 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $2,487,564 | 44,628 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||